Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada / L. Lishman [and nine others].: En13-5/05-183E-PDF
"Over the last ten years there have been reports of pharmaceuticals and personal care product (PPCP) residuals in municipal wastewater treatment plant (WWTP) effluents. The goals of this study were: (1) to expand the Canadian database of municipal wastewater influent and effluent concentrations for selected PPCPS; (2) to determine if three treatment configurations (e.g. lagoons, conventional activated sludge (CAS), and CAS followed by media filtration (CAS + filtration)) affect PPCP reduction; (3) to explore whether CAS operational parameters were correlated with reduction. Selected PPCPs included ten acidic pharmaceuticals, triclosan, five polycyclic musks and two estrogens. The pharmaceuticals and musks were selected on the basis of levels of use in Canada; reported aquatic toxicity effects; and the ability to analyze for the compounds at low levels. Twelve WWTPs discharging into the Thames River, the second largest river in southwestern Ontario, were surveyed"--Abstract.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.872216&sl=0
| Department/Agency |
|
|---|---|
| Title | Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada / L. Lishman [and nine others]. |
| Series title |
|
| Publication type | Monograph - View Master Record |
| Language | [English] |
| Format | Digital text |
| Electronic document | |
| Note(s) |
|
| Publishing information |
|
| Author / Contributor |
|
| Description | 1 online resource (39 pages). |
| Catalogue number |
|
| Subject terms |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.Page details
- Date modified: